20
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Effects of 50 Hz magnetic fields on UV-induced skin tumourigenesis in ODC-transgenic and non-transgenic mice

, , , , , , , & show all
Pages 113-121 | Published online: 03 Jul 2009

  • BAUM, A., MEVISSEN, M., KAMINO, K., MOHR, U. and LOSCHER, W., 1995, A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50Hz, 100 µT magnetic field exposure. Carcinogenesis, 16, 119-125.
  • BENIASHVILI, D. S., BILANISHVILI, V. and MENABDE, M. Z., 1991, Low-frequency electromagnetic radiation enhances the induction of rat mammary tumors by nitrosomethyl Urea. Cancer Letters, 61, 75-79.
  • BLACKMAN, C. F., BENANE, S. G., HOUSE, D. E. and POLLOCK, M. M., 1993, Action of 50 Hz magnetic fields on neu rite outgrowth in pheochromocytoma cells. Bioelectromagnetics, 14, 273-286.
  • BYUS, C. V., PIEPER, S. E. and ADEY, W. R., 1987, The effects of low-energy 60-Hz environmental electromagnetic fields upon the growth-related enzyme ornithine decarboxylase. Carcinogenesis, 8, 1385-1389.
  • DE GRUIJL, F. R. and FORBES, P. D., 1995, UV-induced skin cancer in a hairless mouse model. Bioessays, 17, 651-660.
  • FEYCHTING, M. and AHLBOM, A., 1993, Magnetic fields and cancer in children residing near Swedish high-voltage power lines. American Journal of Epidemiology, 138, 467-481.
  • FLODERUS, B., PERSSON, T., STENLUND, C., WENNBERG, A., OST, Å. and KNAVE, B., 1992, Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors. A case-control study in Sweden. Cancer Causes and Control, 4, 465-476.
  • GOLDBERG, R. B. and CREASEY, W. A., 1991, A review of cancer induction by extremely low frequency electromagnetic fields: is there a plausible mechanism? Medical Hypotheses, 35, 265-274.
  • GRAHAM, C., COOK, M. R., COHEN, H. D. and GERKOVICH, M. M., 1994, A dose response study of human exposure to 60Hz electric and magnetic fields. Bioelectromagnetics, 15, 447-463.
  • HALMBKYTÖ, M., ALHONEN, L., WALFORS, J., SINBRVIRTA, R., ELORANTA, T. and JÄNNE, J., 1991b, Characterization of a transgenic mouse line overexpressing human ornithine decarboxylase gene. Biochemical journal, 278, 895-898.
  • HALMEKYTÖ, M., HYTTINEN, J.-M., SINERVIRTA, R. et al., 1991a, A transgenic mouse line with aberrant expression of human ornithine decarboxylase gene, Journal of Biological Chemistry, 266, 19746-19751.
  • HALMEKYTÖ, M., SYRJÄNEN, K., JÄNNE, J. and ALHONEN, L., 1992, Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene. Biochemical and Biophysical Research Communications, 187, 493-497.
  • HILLEBRAND, G. G., WINSLOW, M. S., BENZINGER, M. J., HEITMEYER, D. A. and BISSETT, D. L., 1990, Acute and chronic ultraviolet radiation induction of epidermal ornithine decarboxylase activity in hairless mice. Cancer Research, 50, 1580-1584.
  • JÄNNE, J. and WILLIAMS-ASHMAN, H. G., 1971, On the purification of L-ornithine decarboxylase from rat prostate and effects of thiol compounds on the enzyme, journal of Biological Chemistry, 246, 1725-1732.
  • KOZA, R. A., MEGOSH, L. C., PALMIERI, M. and O'BRIEN, T., 1991, Constitutively elevate levels of ornithine and polyamines in mouse epidermal papillomas. Carcinogenesis, 12, 1619-1625.
  • LITOVITZ, T. A., KRAUSE, D., MONTROSE, C. J. and MULLINS, J., 1994, Temporally incoherent magnetic fields mitigatethe response of biological systems to temporally coherent magnetic fields. Bioeleclromagnelics, 15, 399-40.
  • LITOVITZ, T. A., KRAUSE, D. and MULLINS, J., 1991, Effect of coherence time of the applied magnetic field on ornithine decarboxylase activity. Biochemical and Biophysical Research Communications, 178, 862-865.
  • LOSCHER, W., MEVISSEN, M., LEHMACHER, W. and STAMM, A., 1993, Tumor promotion in a breast cancer model by exposure to a weak alternating magnetic field. Cancer Letters, 71, 71-81.
  • LOWE, N., VERMA, A. and BOUTWELL, R. K., 1978, Ultraviolet light induces epidermal ornithine decarboxylase activity. Journal of Investigative Dermatology, 71, 417-418.
  • LUBEN, R., MORGAN, A. P., CARLSON, A. and DUONG, M., 1994, One gauss 60Hz magnetic fields modulate protein kinase C activity by a mechanism similar to that of tumor promoting phorbol esters. In BEMS Sixteenth Annual Meeting, Copenhagen, June 12-17 (Frederick, MD: The Bioelectromagnetics Society), p. 74.
  • MCKINLAY, A. F. and DIFFEY, B. L., 1987, A reference action spectrum for ultraviolet induced erythema in human skin. CIE Journal, 6, 17-22.
  • MCKNIGHT, B., 1991, Survival analysis. In statistics in Toxicology, edited by D. Krewski and C. Franklin (New York: Gordon and Breach Science Publishers), pp. 471-498.
  • MCLEAN, J. R. N., STUCHLY, M. A., MITCHEL, R. E. J. et al., 1991, Cancer promotion in a mouse-skin model by a 60-Hz magnetic field: II. Tumor development and immune response. Bioelectromagnetics, 12, 273-287.
  • MEGOSH, L., GILMOUR, S. K., ROSSON, D., PERALTA SOLER, A., BLESSING, M., SAWICKI, J. A. and O'BRIEN, T. G., 1995, Increased frequency of skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Research, 55, 4205-4209.
  • MEVISSEN, M., KIETZMANN, M. and LÖSCHER, W., 1995, in vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA. Cancer Letters, 14, 207-214.
  • MEVISSEN, M., LERCHL, A., SZAMBL, M. and LÖSCHER, W., 1996, Exposure of DMBA-treated female rats in a 50-Hz, 50 µT magnetic field: effects on mammary tumor growth, melatonin levels, and T lymphosyte activation. Carcinogenesis, 17, 903-910.
  • MEVISSEN, M., STAMM, A., BUNTENKÖTTER, S., ZWINGELBERG, R., WAHNSCHAFFE, U. and LÖSCHER, W., 1993, Effects of magnetic fields on mammary tumor development induced by 7,12-dimethyl-benz(a)anthracene in rats. Bioelectromagnetics, 14, 131 - 143.
  • MISAKIAN, M., SHEPPARD, A. R., KRAUSE, D., FRAZIER, M. E. and MILLER, D., 1993, Biological, physical, and electrical parameters for in vitro studies with ELF magnetic and electric fields: a primer. Bioelectromagnetics, suppl. 2, 1-73.
  • MORGAN, G. and NAIR, I., 1992, Alternative functional relationships between ELF field exposure and possible health effects: Report on an expert workshop. Bioelectromagnetics, 13, 335-350.
  • NRPB, 1992, Electromagnetic fields and the risk of cancer. Documents of the NRPB, vol. 3, no. 1 (Chilton, UK: National Radiation Protection Board).
  • O'BRIEN, T. G., 1976, The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin Carcinogenesis. Cancer Research, 36, 2644-2653.
  • OLSEN, N. H., NIELSEN, A. and SCHULGEN, G., 1993, Residence near high voltage facilities and risk of cancer in children. British Medical Journal, 307, 891-895.
  • PETO, R., PIKE, M. C., DAY, N. E., GRAY, R. G., LEE, P. N., PARISH, S., PETO, J., RICHARDS, S. and WAHRENDORF, J., 1980, Guidelines for simple, sensitive significance tests for carcinogenic effects. In long-term and short-term screening assays for carcinogens: a critical appraisal. IARC Monographs Suppl. 2.
  • RANNUG, A., HOLMBERG, B., EKSTROM, T., HANSSON MILD, K., GIMBNEZ-CONTI, I. and SLAGA, T., 1994, Intermittent 50Hz magnetic field and skin tumour promotion in Sencar mice. Carcinogenesis, 15, 153-157.
  • STUCHLY, M. A., MCLEAN, J. R. N., BURNETT, R., GODDARD, M., LECUYER, D. W. and MITCHEL, R. E. J., 1992, Modification of tumor promotion in the mouse skin byexposure to an alternating magnetic field. Cancer Leiters, 65, 1-7.
  • VERKASALO, P. K., PUKKALA, E., HONGISTO, M. Y., VALJUS, J. E., JÄRVINEN, P. J., HBIKKILÄ, K. V. and KOSKENVUO, M., 1993, Risk of cancer in Finnish children living close to power lines. British M edicai Journal, 307, 895-899.
  • WILSON, B. W., STEVENS, R. G. and ANDERSON, L. E. eds, 1990, Extremely Low Frequent) Electromagnetic Fields: The Question of Cancer (Columbus, OH: Bauteile Press).
  • YOUNG, A. R., CONNOR, M. J. and LOWE, N. J., 1986, U. V. wavelength dependence for the induction of ornithine decarboxylase activity in hairless mouse skin. Carcinogenesis, 7, 601-604.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.